The development of a novel in vitro discriminatory dissolution method for a class I drug in a matrix tablet formulation.
Farrell
C
C
IVIVR Cooperative Working Group, Elan Corporation, Athlone, Co. Westmeath, Ireland.
Butler
J
J
Stark
P
P
Madden
H
H
Devane
J
J
D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000592:standards; D006801:Humans; D065347:Hypromellose Derivatives; D066298:In Vitro Techniques; D008747:Methylcellulose / Q000031:analogs & derivatives; D004364:Pharmaceutical Preparations / Q000145:classification; D010602:Pharmacopoeias as Topic; D012015:Reference Standards; D013607:Tablets; D014481:United States
D003692:Delayed-Action Preparations; D004364:Pharmaceutical Preparations; D013607:Tablets; D065347:Hypromellose Derivatives; D008747:Methylcellulose